Average Co-Inventor Count = 1.63
ph-index = 26
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Trivascular, Inc. (62 from 100 patents)
2. Boston Scientific Santa Rosa Corp. (8 from 9 patents)
3. Triad Vascular Systems, Inc. (1 from 1 patent)
4. Trivascular2, Inc. (0 patent)
71 patents:
1. 12357483 - Systems and methods for guidewire crossover for bifurcated prostheses
2. 12336920 - Bifurcated endovascular prosthesis having tethered contralateral leg
3. 12226328 - Delivery catheter for endovascular device
4. 12213897 - Tandem modular endograft
5. 12016766 - Modular vascular graft for low profile percutaneous delivery
6. 12004980 - Advanced endovascular graft and delivery system
7. 11779479 - Bifurcated endovascular prosthesis having tethered contralateral leg
8. 11752021 - Stent graft delivery system with access conduit
9. 11717391 - Endovascular graft for aneurysms involving major branch vessels
10. 11439497 - Advanced endovascular graft
11. 11123205 - Tandem modular endograft
12. 11065097 - Advanced kink-resistant stent graft
13. 11013626 - Endovascular delivery system with an improved radiopaque marker scheme
14. 11000390 - Bifurcated endovascular prosthesis having tethered contralateral leg
15. 10987238 - Systems and methods for guidewire crossover for bifurcated prostheses